This brand name is authorized in Nigeria. It is also authorized in Brazil, Ecuador, France, Hong Kong SAR China, Ireland, Japan, Mexico, South Africa, Spain, UK.
The drug ALDOMET contains one active pharmaceutical ingredient (API):
1
|
UNII
56LH93261Y - METHYLDOPA
|
|
Methyldopa is an antihypertensive agent acting centrally by stimulating alpha adrenergic receptors. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-5443 | Tablet | Aldomet Tablet TAB 250 mg 6 x 10 | Aldomet Tablet METHYLDOPA Methyldopa 250mg, Ethyl cellulose 26.2mg, Citric acid anhydrous 4.3mg, Edetate calcium disodium 0.2mg, Colloidal silicon dioxide 2mg, Powdered cellulose 12mg, Magnesium stearate 1.4mg, Alcohol 0.05ml,Jaguar gum A 15mg A4-5443 Drugs Imported Products 610 Prescription Only Medicine (POM) 8/9/2021 ASPEN PHARMACARE NIGERIA LIMITED, plot 28,infinty house,ilupeju bypass 9062496814 dadeduro@ng.aspenpharma.com Aspen Port Elizabeth (Pty) Ltd, Cnr. Fairclough Road & gibaud Road Korsten port Elizabeth 6020 South Africa, South Africa 2.34704E+11 patience.u.fagbenro@gsk.com | 27/07/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| C02AB | Methyldopa | C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting |
| C02AB01 | Methyldopa (levorotatory) | C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting → C02AB Methyldopa |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 1629R |
| BR | Câmara de Regulação do Mercado de Medicamentos | 505609001119416, 505609002115317 |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | H6970913, H6980913 |
| ES | Centro de información online de medicamentos de la AEMPS | 37932, 53587 |
| FR | Base de données publique des médicaments | 60578560, 64651319 |
| GB | Medicines & Healthcare Products Regulatory Agency | 13703, 13736, 178957, 178959 |
| HK | Department of Health Drug Office | 01954 |
| JP | 医薬品医療機器総合機構 | 2145001F1027, 2145001F2040 |
| MX | Comisión Federal para la Protección contra Riesgos Sanitarios | 57518 |
| NG | Registered Drug Product Database | A4-5443 |
| ZA | Health Products Regulatory Authority | C/7.1.3/205 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.